» Articles » PMID: 22789697

Mutation Analysis of VCP in British Familial and Sporadic Amyotrophic Lateral Sclerosis Patients

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 2012 Jul 14
PMID 22789697
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the valosin-containing-protein (VCP) gene are associated with the multidisorder disease, inclusion body myopathy with Pagets and associated frontotemporal dementia. This disease is characterized pathologically by large ubiquitinated, TAR DNA Binding Protein 43 (TDP-43) positive inclusions. These inclusions are also a common feature in neurological diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTLD). Mutations in the VCP gene have been identified in ALS patients, therefore we aimed to characterize VCP variations in our own cohort of familial and sporadic ALS patients by sequencing all 17 coding exons of VCP. This study failed to detect any exonic variations in a subset of British familial and sporadic ALS patients.

Citing Articles

Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases.

Chu S, Xie X, Payan C, Stochaj U Mol Neurodegener. 2023; 18(1):52.

PMID: 37545006 PMC: 10405438. DOI: 10.1186/s13024-023-00639-y.


Phenotype of VCP Mutations in Chinese Amyotrophic Lateral Sclerosis Patients.

Feng S, Lin H, Che C, Huang H, Liu C, Zou Z Front Neurol. 2022; 13:790082.

PMID: 35197922 PMC: 8858817. DOI: 10.3389/fneur.2022.790082.


The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research.

Gentile F, Scarlino S, Falzone Y, Lunetta C, Tremolizzo L, Quattrini A Front Neurosci. 2019; 13:601.

PMID: 31293369 PMC: 6603245. DOI: 10.3389/fnins.2019.00601.


The genetics of amyotrophic lateral sclerosis: current insights.

Alsultan A, Waller R, Heath P, Kirby J Degener Neurol Neuromuscul Dis. 2018; 6:49-64.

PMID: 30050368 PMC: 6053097. DOI: 10.2147/DNND.S84956.


Gene discovery in amyotrophic lateral sclerosis: implications for clinical management.

Al-Chalabi A, van den Berg L, Veldink J Nat Rev Neurol. 2016; 13(2):96-104.

PMID: 27982040 DOI: 10.1038/nrneurol.2016.182.